Test tumor genetic results to guide early trial treatments
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial looks at your tumor’s genetic information from stored tissue to help match you to early-phase treatment options. It may help doctors find a therapy that fits your tumor, especially when standard options have limited benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have an advanced solid tumor or lymphoma confirmed by biopsy or surgery.
- Your daily functioning is good (you’re either fully active or limited but able to care for yourself).
- You are expected to live at least 6 months.
- You have stored tumor tissue (FFPE from a past biopsy or surgery) available for genetic testing.
- You can understand the study and sign consent, and you’re able to follow study visits and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial builds a large database using your existing tumor genetic test results (DNA and/or RNA). It may help researchers better understand advanced cancers and use gene patterns to guide future care.
This early-phase trial tests whether collecting immune cells from your tumor (tumor infiltrating lymphocytes) is safe and can help treat advanced solid cancers. It may help by strengthening your body’s immune attack on the cancer after standard treatments are no longer working.
This study uses your tumor’s genetic test results to help match you to the most suitable treatment when standard options have failed or don’t exist. It may help by targeting therapies based on specific gene changes found in your cancer.
This program gathers tumor samples to study their genetic and immune (immune-system) features across many types of advanced cancer. Your information and tumor testing may help researchers understand which tumor features are present and how they relate to cancer behavior.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.